We demonstrate herein that inhibition of glycolysis preferentially targets malignant cells to suppress ATP production, and that inhibition of glycolysis inactivates ABC transporter activity to retain anti-cancer agents intracellularly and restore their cytotoxic effects on malignant cells. The gene discussed is ABCG2; the disease is cancer.